NO20006255D0 - Krystallinsk efavirenz - Google Patents

Krystallinsk efavirenz

Info

Publication number
NO20006255D0
NO20006255D0 NO20006255A NO20006255A NO20006255D0 NO 20006255 D0 NO20006255 D0 NO 20006255D0 NO 20006255 A NO20006255 A NO 20006255A NO 20006255 A NO20006255 A NO 20006255A NO 20006255 D0 NO20006255 D0 NO 20006255D0
Authority
NO
Norway
Prior art keywords
crystalline efavirenz
efavirenz
crystalline
Prior art date
Application number
NO20006255A
Other languages
English (en)
Other versions
NO20006255L (no
Inventor
Lilian Alicia Radesca
Michael B Maurin
Shelley R Rabel
James R Moore
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22214647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20006255(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO20006255D0 publication Critical patent/NO20006255D0/no
Publication of NO20006255L publication Critical patent/NO20006255L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20006255A 1998-06-11 2000-12-08 Krystallinsk efavirenz NO20006255L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8898198P 1998-06-11 1998-06-11
PCT/US1999/013199 WO1999064405A1 (en) 1998-06-11 1999-06-10 Crystalline efavirenz

Publications (2)

Publication Number Publication Date
NO20006255D0 true NO20006255D0 (no) 2000-12-08
NO20006255L NO20006255L (no) 2001-02-12

Family

ID=22214647

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006255A NO20006255L (no) 1998-06-11 2000-12-08 Krystallinsk efavirenz

Country Status (21)

Country Link
EP (1) EP1086087A1 (no)
JP (1) JP2002517487A (no)
CN (1) CN1307568A (no)
AR (3) AR018670A1 (no)
AU (1) AU758114C (no)
BR (1) BR9911523A (no)
CA (1) CA2333550A1 (no)
EE (1) EE05547B1 (no)
HR (1) HRP990182A2 (no)
HU (1) HUP0103819A3 (no)
IL (1) IL139793A (no)
MY (1) MY126450A (no)
NO (1) NO20006255L (no)
NZ (1) NZ507713A (no)
PL (1) PL198504B1 (no)
SG (3) SG111980A1 (no)
SK (1) SK18182000A3 (no)
TW (1) TWI235152B (no)
UA (1) UA74324C2 (no)
WO (1) WO1999064405A1 (no)
ZA (1) ZA200006173B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965729A (en) 1997-02-05 1999-10-12 Merck & Co., Inc. Process for the crystallization of a reverse transcriptase inhibitor using an anti-solvent
WO2006018853A2 (en) 2004-08-19 2006-02-23 Hetero Drugs Limited Novel polymorphs of efavirenz
PE20060587A1 (es) * 2004-09-02 2006-07-09 Bristol Myers Squibb Co Sintesis de (s)-6-cloro-4-ciclopropiletinil-4-trifluorometil-1,4-dihidro-2h-3,1-benzoxazin-2-ona
WO2008108630A1 (en) * 2007-03-02 2008-09-12 Ultimorphix Technologies B.V. Polymorphic forms of efavirenz
WO2009011567A1 (en) * 2007-07-16 2009-01-22 Ultimorphix Technologies B.V. Crystalline forms of efavirenz
PL2303267T3 (pl) * 2008-02-04 2013-11-29 Pfizer Ltd Polimorficzna postać pochodnej [1,2,4]triazolo[4,3-a]pirydyny do leczenia chorób zapalnych
WO2010073254A2 (en) 2008-12-22 2010-07-01 Hetero Research Foundation Process for preparing efavirenz polymorph
DE102009041443A1 (de) 2009-09-16 2011-03-31 Archimica Gmbh Salze des 6-Chlor-4-(cyclopropylethinyl)-1,4-dihydro-4-(trifluormethyl)-2H-3,1-benzoxazin-2-ons und deren Synthese, Aufreinigung und Anwendung als Vorstufen für Efavirenz
EP2471783A1 (en) 2010-12-23 2012-07-04 Esteve Química, S.A. Novel polymorphic form of efavirenz
CN103508973B (zh) * 2012-06-25 2016-04-27 上海迪赛诺药业有限公司 制备依非韦伦i型结晶的方法
CN102924398B (zh) * 2012-11-22 2015-11-18 安徽贝克生物制药有限公司 用于除去依非韦伦对应异构体的方法
WO2014114971A1 (en) * 2013-01-23 2014-07-31 Alienor Farma Increased dosage of efavirenz for the treatment of cancer
CN105037175B (zh) * 2014-07-18 2017-02-22 盐城迪赛诺制药有限公司 一种用于提高依非韦伦中间体光学纯度的方法
CN105001101B (zh) * 2015-05-28 2017-11-28 乐平市瑞盛制药有限公司 一种4‑氯‑2‑三氟乙酰基苯胺水合物盐酸盐的合成方法
CN108947855B (zh) * 2018-08-10 2021-10-22 江苏沙星化工有限公司 一种依非韦伦关键中间体的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one
AU3736197A (en) * 1996-07-26 1998-02-20 Du Pont Pharmaceuticals Company A practical synthesis of benzoxazinones useful as hiv reverse transcripta se inhibitors
DE69724630T2 (de) * 1996-10-02 2004-07-29 Bristol-Myers Squibb Pharma Co. 4,4-disubstituierte 1,4-dihydro-2h-3,1-benzoxazin-2-one die anwendbar sind als hiv-reverstranskriptase-inhibitoren, zwischenprodukte und verfahren zu ihrer herstellung
DE69841972D1 (de) * 1997-02-05 2010-12-09 Merck Sharp & Dohme Verfahren zur kristallisation eines reverstranskriptase-inhibitors, bei welchem ein anti-lösungsmittel benutzt wird

Also Published As

Publication number Publication date
HUP0103819A2 (hu) 2002-02-28
PL198504B1 (pl) 2008-06-30
SG134977A1 (en) 2007-09-28
EE05547B1 (et) 2012-06-15
NO20006255L (no) 2001-02-12
SG111981A1 (en) 2005-06-29
EE200000743A (et) 2002-10-15
PL345221A1 (en) 2001-12-03
WO1999064405A1 (en) 1999-12-16
MY126450A (en) 2006-10-31
AR077407A2 (es) 2011-08-24
IL139793A (en) 2006-10-31
CA2333550A1 (en) 1999-12-16
ZA200006173B (en) 2001-10-31
JP2002517487A (ja) 2002-06-18
AR018670A1 (es) 2001-11-28
UA74324C2 (uk) 2005-12-15
AU4436499A (en) 1999-12-30
CN1307568A (zh) 2001-08-08
HRP990182A2 (en) 2000-02-29
SK18182000A3 (sk) 2001-08-06
EP1086087A1 (en) 2001-03-28
NZ507713A (en) 2003-08-29
IL139793A0 (en) 2002-02-10
TWI235152B (en) 2005-07-01
AU758114B2 (en) 2003-03-13
BR9911523A (pt) 2001-09-18
AU758114C (en) 2003-10-30
AR077469A2 (es) 2011-08-31
HUP0103819A3 (en) 2003-05-28
SG111980A1 (en) 2005-06-29

Similar Documents

Publication Publication Date Title
DE69910192D1 (de) Kabeltrommel
DE59912371D1 (de) Gleitschalungsfertiger
DE69924838D1 (de) Einlasslufterhitzmodule
PT1119430E (pt) Fresa
ID23287A (id) Trisiklik tersubstitusi
EE200100135A (et) EtO2C-CH2-(R)Cgl-Aze-Pab-OH kristalsed vormid
DE59906732D1 (de) Verstellmechanismus
ID24221A (id) Tempat patrum
DE69931392D1 (de) Hautdepigmentierungsmittel
EE200000743A (et) Kristalliline efavirens
DE69714228D1 (de) Kristalline metallophosphate
ID23219A (id) Trisiklik tersubstitusi
NO20010181D0 (no) Jordprövetaker
DE69941474D1 (de) Lichtstrahlabtastgerät
FI980222A0 (fi) Stycke av isoleringsaemne med en genomgaoende primaerstroemledning
PT1102747E (pt) Formas cristalinas do osanetant
DE59808995D1 (de) Endomikroskopsystem
FI980856A0 (fi) Andningsskydd utrustad med en identifierare
ATE303996T1 (de) Substituierte acylaminophenyl-uracile
DE59912188D1 (de) Substituierte phenyluracile
DE69932075D1 (de) Aufzugsschachttuerstruktur
DE69939197D1 (de) Münzschiebespielgerät
PT1076660E (pt) (4-bromopirazol-3-il)-benzazolos substituidos
DE69938364D1 (de) Polycarbonatabmischung
FI980053A0 (fi) Anordning foer utformande av fiberbollar av laongstraeckta fibrer som foeljer med enluftstroem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application